How big is the Glaucoma Treatment Market?

The Glaucoma Treatment Market size is expected to reach USD 6.40 billion in 2024 and grow at a CAGR of 4.60% to reach USD 8.02 billion by 2029. Read More

What is the current Glaucoma Treatment Market size?

In 2024, the Glaucoma Treatment Market size is expected to reach USD 6.40 billion. Read More

Who are the key players in Glaucoma Treatment Market?

AERIE PHARMACEUTICALS, INC., Akorn, Incorporated, Allergan Plc, Bausch & Lomb Incorporated and Novartis AG are the major companies operating in the Glaucoma Treatment Market. Read More

Which is the fastest growing region in Glaucoma Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Glaucoma Treatment Market?

In 2024, the North America accounts for the largest market share in Glaucoma Treatment Market. Read More

What years does this Glaucoma Treatment Market cover, and what was the market size in 2023?

In 2023, the Glaucoma Treatment Market size was estimated at USD 6.11 billion. The report covers the Glaucoma Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Glaucoma Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Glaucoma Treatment Market Share

Statistics for the 2023 & 2024 Glaucoma Treatment market share, created by Mordor Intelligence™ Industry Reports. Glaucoma Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Glaucoma Treatment Industry

The market studied is a consolidated market owing to the presence of few major market players. Some of the market players are AERIE PHARMACEUTICALS, INC., Akorn, Incorporated, Allergan Plc, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc, and Santen Pharmaceutical Co., Ltd.